Australasian Biotechnology,
Volume 8 Number 4, July/August 1998, pp. 215-221
Conference Paper: Biotech '98 An Update
by G. Steven Burrill
Code Number:AU98029
Sizes of Files:
Text: 21K
Graphics: Line drawings
(gif) - 19K
Cheers and Fears Continue for Bioscience Companies,
Investors
Highlights Summary
- Biotech '98 - A summary of 1997 reflects:
- Europe is hot.
- Investors were hammered on the clinical side, rewarded
nicely on the genomic and toolbox side.
- Massive transition continues in the pharmaceutical world.
- Unexpected results in some quarters have raised
uncertainties to higher levels.
- Venture capitalists are in love with the Internet, leaving
bioscience at the altar.
Copyright 1998 Australian Biotechnology Association Ltd.
